Will the New COVID-19 Vaccine Work Against the BA.2.86 Variant?

United Kingdom News News

Will the New COVID-19 Vaccine Work Against the BA.2.86 Variant?
United Kingdom Latest News,United Kingdom Headlines
  • 📰 TIME
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 53%

An updated COVID-19 vaccine is expected in September, but new variants like BA.2.86 are already spreading in the U.S.

that weren’t around even three months ago, remind us that SARS-CoV-2 is still a health threat for the coming fall and winter.

Based on the June recommendation, vaccine makers have been manufacturing updated vaccines that target XBB, in order to ensure enough doses are ready by the fall and winter season. How well do these vaccines work against the newer variants?that its XBB-based vaccine can neutralize the newer EG.5 and FL.1.5.1 variants as well as XBB. The results were based on early findings from a study the company conducted to test its vaccine in a small group of people.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

TIME /  🏆 93. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Researchers on the cusp of a new vaccine modality breakthroughResearchers on the cusp of a new vaccine modality breakthroughProfessor Bernd Rehm and Dr. Shuxiong Chen from the Griffith Institute for Drug Discovery (GRIDD) and Griffith's Center for Cell Factories and Biopolymers have succeeded in developing a new vaccine modality that is a stable particulate vaccine.
Read more »

Researchers find vaccine may reduce severity of long-haul COVID symptomsResearchers find vaccine may reduce severity of long-haul COVID symptomsGetting a COVID-19 vaccine may not only reduce a person's risk of getting long-haul COVID, but also could mean fewer symptoms for people who develop the condition.
Read more »

Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data showsNovavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data showsNovavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.
Read more »

US warns new spreading Covid variant could be most infectious yetUS warns new spreading Covid variant could be most infectious yetOfficials have confirmed the presence of BA.2.86, a highly mutated form of Covid-19, in wastewater within the United States.
Read more »

Griffith on the brink of technological breakthrough in vaccine developmentGriffith on the brink of technological breakthrough in vaccine developmentGriffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality.
Read more »



Render Time: 2025-02-24 01:30:58